Lyell Immunopharma (LYEL) Shares Outstanding (Entity) (2021 - 2026)
Lyell Immunopharma (LYEL) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Lyell Immunopharma | 276.08 Mn | 276.08 Mn | - | 23.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.33 Mn |
| Dec 31, 2025 | 17.09 Mn |
| Sep 30, 2025 | 19.29 Mn |
| Jun 30, 2025 | 14.83 Mn |
| Mar 31, 2025 | 14.76 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 12.83 Mn |
| Jun 30, 2024 | 12.80 Mn |
| Mar 31, 2024 | 12.75 Mn |
| Dec 31, 2023 | 12.70 Mn |
| Sep 30, 2023 | 12.59 Mn |
| Jun 30, 2023 | 12.55 Mn |
| Mar 31, 2023 | 12.48 Mn |
| Dec 31, 2022 | 12.48 Mn |
| Sep 30, 2022 | 12.46 Mn |
| Jun 30, 2022 | 12.36 Mn |
| Mar 31, 2022 | 12.27 Mn |
| Dec 31, 2021 | 6,796.00 |
| Sep 30, 2021 | 11,969.00 |
| Jun 30, 2021 | 2,136.00 |